| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.1 |